Panbela Therapeutics, Inc. Revenue
Panbela Therapeutics, Inc. reported Revenue of $291.26 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2015-08-13
- Panbela Therapeutics, Inc. revenues for the quarter ending 2015-06-30 was $291.26K, a 5.94% decline year-over-year.
- Panbela Therapeutics, Inc. revenues for the quarter ending 2015-03-31 was $287.26K, a 18.29% increase year-over-year.
- Panbela Therapeutics, Inc. revenues for the quarter ending 2014-12-31 was $513.14K, a 68.39% increase year-over-year.
- Panbela Therapeutics, Inc. revenues for the quarter ending 2014-09-30 was $291.38K, a 18.43% increase year-over-year.
- Panbela Therapeutics, Inc. revenues for fiscal 2014 was $1.36M, a 39.35% increase from fiscal 2013.
- Panbela Therapeutics, Inc. revenues for fiscal 2013 was $973.81K, a 21.00% decline from fiscal 2012.
- Panbela Therapeutics, Inc. revenues for fiscal 2012 was $1.23M, a 76.16% increase from fiscal 2011.
- Panbela Therapeutics, Inc. revenues for fiscal 2011 was $699.75K.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2015-06-30 | $291.26K 10-Q · filed 2015-08-13 | $578.51K 10-Q · filed 2015-08-13 | $1.09M derived: sum of 3 quarters · filed 2015-08-13 | $1.38M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2015-03-31 | $287.26K 10-Q · filed 2015-05-15 | $800.40K derived: sum of 2 quarters · filed 2015-05-15 | $1.09M derived: sum of 3 quarters · filed 2015-05-15 | $1.40M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-12-31 | $513.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $804.52K derived: sum of 2 quarters · filed 2015-03-30 | $1.11M derived: sum of 3 quarters · filed 2015-08-13 | $1.36M 10-K · filed 2015-03-30 | |
| 2014-09-30 | $291.38K 10-Q · filed 2014-11-14 | $601.02K derived: sum of 2 quarters · filed 2015-08-13 | $843.85K 10-Q · filed 2014-11-14 | $1.15M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-06-30 | $309.64K 10-Q · filed 2015-08-13 | $552.47K 10-Q · filed 2015-08-13 | $857.21K derived: sum of 3 quarters · filed 2015-08-13 | $1.10M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | $242.83K 10-Q · filed 2015-05-15 | $547.57K derived: sum of 2 quarters · filed 2015-05-15 | $793.61K derived: sum of 3 quarters · filed 2015-05-15 | $1.01M derived: sum of 4 quarters · filed 2015-05-15 | |
| 2013-12-31 | $304.74K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $550.78K derived: sum of 2 quarters · filed 2015-03-30 | $769.59K derived: sum of 3 quarters · filed 2015-03-30 | $973.81K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $246.04K 10-Q · filed 2014-11-14 | $464.85K derived: sum of 2 quarters · filed 2014-11-14 | $669.08K 10-Q · filed 2014-11-14 | $1.08M derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | $218.81K 10-Q · filed 2013-08-14 | $423.04K 10-Q · filed 2014-08-14 | $829.78K derived: sum of 3 quarters · filed 2014-08-14 | $1.16M derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $218.81K 10-Q · filed 2014-08-14 | $204.22K 10-Q · filed 2013-05-15 | $610.97K derived: sum of 2 quarters · filed 2014-08-14 | $938.39K derived: sum of 3 quarters · filed 2014-08-14 | $1.24M derived: sum of 4 quarters · filed 2014-08-14 |
| 2012-12-31 | $392.15K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $719.58K derived: sum of 2 quarters · filed 2014-03-28 | $1.02M derived: sum of 3 quarters · filed 2014-03-28 | $1.23M 10-K · filed 2014-03-28 | |
| 2012-09-30 | $327.42K 10-Q · filed 2013-11-14 | $632.11K derived: sum of 2 quarters · filed 2013-11-14 | $840.55K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $304.69K 10-Q · filed 2013-08-14 | $513.13K 10-Q · filed 2013-08-14 | |||
| 2012-03-31 | $208.44K 10-Q · filed 2013-05-15 | ||||
| 2011-12-31 | $699.75K 10-K · filed 2013-03-26 |